Alliance Pharmaceutical Corp.

Gwen H Rosenberg

Stephen F Flaim

Peter E Keipert

N Simon Faithfull

A method of ameliorating tissue damage resulting from hypoxia or ischemia by administering systemically a synthetic oxygen carrier to an individual having or suspected of having blood vessel obstruction is disclosed. A synthetic oxygen carrier in a physiologically acceptable vehicle, wherein the synthetic oxygen carrier comprises submicron sized particles capable of passing through emboli-obstructed blood vessels is also disclosed.

Amelioration of ischemic damage using synthetic oxygen carriers

A multiple method step for delivering a medicament to the lungs, in connection with which, a biocompatible perfluorocarbon liquid is introduced into the lungs and the a microparticulate medicament is introduced into the lungs where it is dispersed into the pulmonary spaces which are filled or coated with the perfluorocarbon liquid.

Growing community of inventors

Rancho Santa Fe, CA, United States of America

Gwen H Rosenberg